Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

352.50 3.50 (1.00%)

2.7M

NSE+BSE Volume

NSE 09 Oct, 2025 3:31 PM (IST)

US FDA Approval

Biocon's arm gets US FDA nod for its ANDA for Rifaximin tablets, with a $1.8 billion market size See details

Biocon Ltd. Delivery Percentage and Volume Analysis for NSE and BSE as of 10 Oct, 2025

Biocon Ltd. Delivery Traded Volume, Percentages, Week Average and Analysis for NSE and BSE as of 10 Oct, 2025

Date

BSE NSE NSE + BSE

Delivery Stock Screeners